Wise Health System – Leveraging MedeAnalytics to Manage its Revenue Life Cycle

Earlier last month, MedeAnalytics announced that Wise Health System, based in Decatur, Texas and affiliated with Baylor Scott & White Health, will expand its partnership with MedeAnalytics by leveraging its analytics platform and deep financial expertise across all segments of the revenue cycle – patient access, mid-cycle and the business office. 

Following the announcement, Lynn Giddens-Branscum, Revenue Cycle Director at Wise Health System, spoke with Jacqueline DiChiara of RevCycleIntelligence.com to offer her perspective on the following:

  • how providers and patients alike are left behind when revenue cycle snares ensue
  • where top industry focuses are as the end of 2015 comes to a close

During the interview, Lynn also discussed how Wise Health System is striving to gain a more holistic view into their revenue cycle with the help of MedeAnalytics to improve their real-time data collection and point-of-service endeavors.

For example, “helping patients better understand the caveats within their policies so they'll have a realistic expectation of what their patient portions are going to be helps the revenue cycle.”

For additional insights from Wise Health System, check out the complete article here

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.

Leave a Comment





Get our take on industry trends

MedeAnalytics at HIMSS26: Turning Insight into Measurable Healthcare Performance

March 9-12, 2026   |   Venetian Convention & Expo Center   |   Las Vegas   As margin pressure intensifies and value-based care…

Read on...

Turning social risk into measurable financial performance

Payers increasingly recognize that social risk factors materially influence total cost of care, utilization, and quality performance. Yet for many…

Read on...

The GLP-1 Insights Series, Part 2: Maximizing impact and savings through analytics

GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers…

Read on...

The GLP-1 Insights Series, Part 1: Long-term impact on costs and outcomes for payers and providers

Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally…

Read on...